Efficacy and safety of insulin degludec biosimilar B01411 versus originator insulin degludec in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs: a multicenter, randomized, open-label, phase 3 study

HS-IDeg and NN-IDeg demonstrated similar efficacy and safety over 18 weeks of treatment in Chinese patients with T2DM who had inadequate responses to OADs for at least 3 months.

Authors

Institutions

Publication Details

Journal
Current Medical Research and Opinion
Published
2024-09-05
DOI
https://doi.org/10.1080/03007995.2024.2401096
Citations
1
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
0.36

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of insulin degludec biosimilar B01411 versus originator insulin degludec in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs: a multicenter, randomized, open-label, phase 3 study

Yibing Lu, Chengwei Song, Linong Ji, Yunming Gao et al.
1 citations
Current Medical Research and Opinion
Diabetes Management and Research
0.36
article

Efficacy and safety of insulin degludec biosimilar B01411 versus originator insulin degludec in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs: a multicenter, randomized, open-label, phase 3 study

Yibing Lu, Chengwei Song, Linong Ji, Yunming Gao, Hongwei Ling, Leili Gao, Wenli Sun, Shu Li, Zhifeng Cheng, Jie Liu, Jingfang Sun, Guoqing Ma, Jianlin Geng, Haifang Wang, Mei‐Ying Liu
article en
1 citations

Abstract

HS-IDeg and NN-IDeg demonstrated similar efficacy and safety over 18 weeks of treatment in Chinese patients with T2DM who had inadequate responses to OADs for at least 3 months.

Current Medical Research and OpinionVol. 40(10)
Handan College (CN), Harbin Medical University (CN), Xuzhou Medical College (CN), Peking University (CN), Jilin Province Tumor Hospital (CN), First Affiliated Hospital of Heilongjiang University of Chinese Medicine (CN), Baogang Group (China) (CN), Fourth Affiliated Hospital of Harbin Medical University (CN), Peking University People's Hospital (CN), The First People’s Hospital of Lianyungang (CN), Yueyang Second People's Hospital (CN), First Affiliated Hospital of Henan University of Science and Technology (CN), Harrison International Peace Hospital (CN), Second Affiliated Hospital of Nanjing Medical University (CN), Huizhou Central People's Hospital (CN), Xian Yang Central Hospital (CN)
Marathon
Good health and well-being
Openalex Percentile: Top 34%
Diabetes Management and Research
0.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.